NVST Envista Holdings Corp

$27.60 +0.73%

Updated 16 d ago

Healthcare · Dental Equipment & Supplies

Envista Holdings Corp (NVST) is a healthcare company in the Dental Equipment & Supplies industry, with a market capitalization of $4.4 billion. Shares last traded at $27.60, 9.1% below their 52-week high. Over the past year the stock is up 35.9%. NVST trades at a price-to-earnings ratio of 46.66, above the Healthcare median of 27.46. Net profit margin is 3.3%, above the peer median of -1.5%. Revenue grew 8.3% year over year.

Market Cap

$4.4B

Shares Out

160.6M

EPS (TTM)

$1.13

P/E Ratio

24.42

P/S Ratio

1.55

P/B Ratio

1.44

Dividend / Share

—

Dividend Yield

—

52-Week High

$30.36

52-Week Low

$18.79

Volume

250,185

Avg Vol (3m)

204,527.889

Performance

+0.62%

-3.63%

+20.68%

-1.20%

YTD

+27.31%

+35.86%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

52.58

SMA (50)

$27.20

SMA (200)

$25.26

Price vs SMA50

+1.45%

Price vs SMA200

+9.28%

ATR (14)

$1.11

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue

$2.9B

Net Income

$95M

Gross Margin

55.2%

Operating Margin

9.6%

Net Margin

3.3%

Return on Equity

3.1%

Return on Assets

1.7%

Current Ratio

2.43

Debt / Equity

0.47

Revenue Growth (YoY)

+8.3%

Latest reported annual period ending 2026-07-03 · SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Recent earnings

Period	EPS (diluted)	Reported
Q2 2026	$0.56	2026-08-05
Q1 2026	$0.23	2026-05-06
FY 2025	$0.28	2026-02-12
Q3 2025	$0.08	2025-10-30
Q2 2026	$0.26	2026-08-05
Q1 2026	$0.10	2026-05-06

Full earnings history →

Healthcare peers

NVST vs 14 sector peers (Healthcare), by market cap. Updated 16 d ago

P/E vs peers

46.66 / 27.46 med

+70% premium

P/S vs peers

1.55 / 4.47 med

-65% discount

Net margin vs peers

3.3% / -1.5% med

above median

1–14 of 14


LLY	Lilly (Eli)	$1.09T	40.86	13.70	33.5%	-0.02%
JNJ	Johnson & Johnson	$670.6B	31.88	6.85	21.5%	+1.04%
ONC	Beone Medicines Ltd.	$535.9B	817.25	87.43	10.7%	+0.23%
ABBV	AbbVie	$459.8B	72.87	7.14	9.8%	-0.57%
MRK	Merck	$375.8B	118.44	5.65	4.8%	+0.44%
AMGN	Amgen	$240.1B	27.47	6.30	23.0%	+0.31%
TMO	Thermo Fisher Scientific	$228.7B	32.82	4.94	15.0%	+1.66%
KLAC	KLA Corporation	$225.9B	46.76	16.64	35.6%	+0.37%
ABT	Abbott Laboratories	$189.5B	30.20	4.20	13.9%	-1.50%
GILD	Gilead Sciences	$187.5B	-57.87	6.16	-10.6%	+1.09%
PFE	Pfizer	$164.2B	37.91	2.58	6.8%	-0.76%
DHR	Danaher Corporation	$148.3B	37.05	5.91	15.9%	+0.49%
VRTX	Vertex Pharmaceuticals	$141.5B	32.11	11.24	35.0%	+0.24%
BMY	Bristol Myers Squibb	$139.1B	14.98	2.83	18.9%	+0.62%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.